Phathom Pharmaceuticals Inc (PHAT) stock news · rev $175.1M
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
This PHAT news page leads with what Phathom Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for PHAT yet. We will not pad this page with generic market recap.
Latest reported PHAT revenue for 2025-12-31 was $175.1M. Net income was -$221.2M. Revenue was up 216.9% from 2024-12-31 to 2025-12-31. PHAT currently screens at market cap $622.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PHAT stock page; for the tape open the quote page.
PHAT stock news FAQ
What are PHAT's latest revenue and net income?
Latest cached Phathom Pharmaceuticals Inc (PHAT) revenue for Dec 31, 2025 was $175.1M. Net income was -$221.2M. Statements: https://lician.com/financials/phat
How did PHAT revenue change from the prior cached period?
Cached Phathom Pharmaceuticals Inc (PHAT) revenue was up 216.9% from $55.3M (Dec 31, 2024) to $175.1M (Dec 31, 2025). Statements: https://lician.com/financials/phat
What is PHAT's market cap?
Phathom Pharmaceuticals Inc (PHAT) market cap is $622.7M on the latest cached fundamentals snapshot.
What kind of company is PHAT?
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Where is PHAT stock news listed?
Cached stock news for Phathom Pharmaceuticals Inc (PHAT) is listed at https://lician.com/news/phat. Filings: https://lician.com/sec/phat
Not investment advice.